WallStreetZenWallStreetZen

NYSE: RMD
Resmed Inc Stock Ownership - Who owns Resmed?

Insider buying vs selling

Have Resmed Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Michael J. RiderGlobal General Counsel2024-03-0481$180.00
$14.58kSell
Michael J. RiderGlobal General Counsel2024-03-01200$173.25
$34.65kSell
Peter C. FarrellDirector2024-02-2210,935$182.66
$2.00MSell
Brett SandercockChief Financial Officer2023-11-273,000$152.62
$457.86kSell
Michael J. FarrellChief Executive Officer2023-11-202,352$148.94
$350.31kSell
Kaushik GhoshalPresident SaaS Business2023-11-20366$148.94
$54.51kSell
Robert Andrew DouglasPresident and COO2023-11-201,375$148.94
$204.79kSell
Michael J. FarrellChief Executive Officer2023-11-202,352$148.94
$350.31kSell
Michael J. FarrellChief Executive Officer2023-11-202,352$148.94
$350.31kSell
Michael J. FarrellChief Executive Officer2023-11-161,343$148.90
$199.97kSell

1 of 6

RMD insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when RMD insiders and whales buy or sell their stock.

RMD Shareholders

What type of owners hold Resmed Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Vanguard Group Inc12.06%17,743,457$3.26BInstitution
Blackrock Inc8.33%12,248,180$2.25BInstitution
State Street Corp4.28%6,290,089$1.16BInstitution
Geode Capital Management LLC2.34%3,435,280$631.34MInstitution
Fmr LLC1.72%2,529,218$464.82MInstitution
Invesco Ltd1.32%1,947,175$357.85MInstitution
Morgan Stanley1.19%1,744,028$320.52MInstitution
Christopher G. Roberts1.16%1,700,337$312.49MInsider
Northern Trust Corp0.99%1,451,951$266.84MInstitution
Norges Bank0.92%1,360,110$249.96MInstitution

1 of 3

RMD vs Medical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
RMD54.49%4.30%Net SellingNet Selling
WST94.34%3.67%Net BuyingNet Buying
BAX84.81%15.19%Net SellingNet Selling
COO24.31%0.86%Net SellingNet Selling
HOLX86.75%13.25%Net SellingNet Selling

Resmed Stock Ownership FAQ

Who owns Resmed?

Resmed (NYSE: RMD) is owned by 54.49% institutional shareholders, 4.30% Resmed insiders, and 41.21% retail investors. Christopher G. Roberts is the largest individual Resmed shareholder, owning 1.70M shares representing 1.16% of the company. Christopher G. Roberts's Resmed shares are currently valued at $311.88M.

If you're new to stock investing, here's how to buy Resmed stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.